Go Pro

BioCryst Pharmaceuticals (BCRX) Institutional Ownership

BioCryst Pharmaceuticals logo
$9.84 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$9.82 -0.02 (-0.18%)
As of 08:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for BioCryst Pharmaceuticals (NASDAQ:BCRX)

Current
Institutional Ownership
Percentage
85.88%
Number of
Institutional Buyers
(last 12 months)
189
Total
Institutional Inflows
(last 12 months)
$916.87M
Number of
Institutional Sellers
(last 12 months)
110
Total
Institutional Outflows
(last 12 months)
$269.06M
Get BCRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioCryst Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

BCRX Institutional Buying and Selling by Quarter

BioCryst Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/18/2026Pacer Advisors Inc.1,563,040$14.88M0.0%N/A0.615%
6/4/2026Seven Fleet Capital Management LP102,493$976K0.3%N/A0.040%
6/3/2026NewEdge Advisors LLC52,326$498K0.0%+4.6%0.021%
5/29/2026Perceptive Advisors LLC7,434,033$70.77M1.4%+135.1%2.925%
5/19/2026Bank of America Corp DE5,091,765$48.47M0.0%+231.6%2.003%
5/19/2026Janus Henderson Group PLC8,908,506$84.85M0.0%+20.3%3.505%
5/18/2026ADAR1 Capital Management LLC105,000$1M0.1%+133.3%0.041%
5/18/2026California State Teachers Retirement System258,345$2.46M0.0%+34.7%0.102%
5/18/2026Royal Bank of Canada18,115$173K0.0%-88.8%0.007%
5/18/2026Rock Springs Capital Management LP12,600$120K0.0%N/A0.005%
5/18/2026Elmind Capital LP1,000,000$9.52M2.7%-53.5%0.393%
5/18/2026Eversept Partners LP3,039,820$28.94M1.5%+1.6%1.196%
5/16/2026The Manufacturers Life Insurance Company 102,042$971K0.0%+4.5%0.040%
5/16/2026Quantinno Capital Management LP80,061$762K0.0%+245.8%0.032%
5/16/2026SummitTX Capital L.P.41,165$392K0.0%N/A0.016%
5/16/2026Lazard Asset Management LLC36,360$346K0.0%-47.8%0.014%
5/16/2026Orbimed Advisors LLC1,425,200$13.57M0.2%-18.2%0.561%
5/15/2026Weiss Asset Management LP82,100$782K0.0%N/A0.032%
5/15/2026Rice Hall James & Associates LLC2,230,105$21.23M1.2%+17.1%0.877%
5/15/2026Entropy Technologies LP75,908$723K0.0%+34.3%0.030%
5/14/2026Healthcare of Ontario Pension Plan Trust Fund1,227,040$11.68M0.0%N/A0.483%
5/14/2026Renaissance Technologies LLC776,990$7.40M0.0%-63.5%0.306%
5/14/2026Hilltop Holdings Inc.10,310$98K0.0%N/A0.004%
5/14/2026Caxton Associates LLP20,567$196K0.0%-46.1%0.008%
5/14/2026Sei Investments Co.150,264$1.43M0.0%+45.7%0.059%
5/14/2026State of Wyoming103,862$989K0.1%+100.1%0.041%
5/13/2026Cetera Investment Advisers48,413$461K0.0%+292.6%0.019%
5/13/2026First Trust Advisors LP800,900$7.63M0.0%+113.6%0.315%
5/7/2026Dimensional Fund Advisors LP2,690,651$25.62M0.0%+119.0%1.059%
5/7/2026Swiss National Bank408,668$3.89M0.0%+3.6%0.161%
5/5/2026Bank of New York Mellon Corp637,658$6.07M0.0%+4.9%0.251%
5/5/2026IMC Chicago LLC631,290$6.01M0.0%N/A0.248%
5/5/2026Sanctuary Advisors LLC55,678$530K0.0%-4.9%0.022%
5/5/2026Hillsdale Investment Management Inc.639,100$6.08M0.2%+14.3%0.252%
5/4/2026Empirical Financial Services LLC d.b.a. Empirical Wealth Management44,237$421K0.0%+34.4%0.017%
5/4/2026Principal Financial Group Inc.430,558$4.10M0.0%+14.3%0.169%
5/1/2026Candriam S.C.A.2,286,841$21.77M0.1%N/A0.900%
4/30/2026Hsbc Holdings PLC31,499$303K0.0%+30.5%0.012%
4/30/2026Kestra Advisory Services LLC15,740$150K0.0%+20.5%0.006%
4/30/2026Personal CFO Solutions LLC21,667$206K0.0%-65.3%0.009%
Elon Musk on His New Invention: “An Infinite Money Glitch.” (Ad)

Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's latest AI patent as the catalyst behind their next major call. They say a market pattern with a 100% historical track record is converging with this new breakthrough by end of month. The last time conditions aligned like this, investors had the chance to turn $10,000 into as much as $350,000 in roughly 12 months. Brown and Chaikin have released the full details for investors who want to get ahead of it.tc pixel

See Jeff Brown and Marc Chaikin's full analysis and next steps here
4/24/2026Capricorn Fund Managers Ltd202,900$1.93M0.3%N/A0.081%
4/23/2026Inspire Investing LLC53,879$513K0.0%-10.3%0.021%
4/22/2026Janney Montgomery Scott LLC163,266$1.55M0.0%+524.8%0.065%
4/22/2026Pictet Asset Management Holding SA471,573$4.46M0.0%-36.3%0.188%
4/21/2026Cannon Global Investment Management LLC26,600$253K0.5%N/A0.011%
4/20/2026RFG Advisory LLC2,870,700$27.33M0.5%N/A1.145%
4/20/2026OP Asset Management Ltd1,252,863$11.93M0.1%N/A0.500%
4/20/2026Assenagon Asset Management S.A.232,947$2.22M0.0%-35.2%0.093%
4/16/2026SG Americas Securities LLC20,649$197K0.0%-83.7%0.008%
3/20/2026Hsbc Holdings PLC24,133$188K0.0%-61.0%0.010%
3/17/2026Rockefeller Capital Management L.P.26,797$209K0.0%+403.2%0.011%
2/19/2026Invesco Ltd.1,354,897$10.57M0.0%+40.8%0.643%
2/18/2026Mackenzie Financial Corp150,728$1.15M0.0%+16.6%0.072%
2/18/2026NewEdge Advisors LLC50,041$390K0.0%N/A0.024%
2/18/2026XTX Topco Ltd17,111$133K0.0%N/A0.008%
2/18/2026Voloridge Investment Management LLC449,743$3.51M0.0%-53.0%0.213%
2/18/2026Vestal Point Capital LP2,250,000$17.55M0.6%N/A1.068%
2/18/2026Virtus Investment Advisers LLC90,278$704K0.2%+111.3%0.043%
2/18/2026Wellington Management Group LLP86,520$675K0.0%-7.5%0.041%
2/18/2026Susquehanna Portfolio Strategies LLC778,521$6.07M0.1%N/A0.369%
2/18/2026Tudor Investment Corp ET AL114,541$893K0.0%+16.7%0.054%
2/18/2026Twinbeech Capital LP23,700$185K0.0%-87.9%0.011%
2/18/2026Sphera Funds Management LTD.837,889$6.54M1.2%N/A0.398%
2/18/2026Quantessence Capital LLC13,200$103K1.2%N/A0.006%
2/18/2026Orbimed Advisors LLC1,741,800$13.59M0.3%+93.2%0.827%
2/18/2026Perceptive Advisors LLC3,162,529$24.67M0.4%N/A1.501%
2/18/2026Millennium Management LLC137,626$1.07M0.0%-70.1%0.065%
2/18/2026Man Group plc407,850$3.18M0.0%+15.1%0.194%
2/18/2026Ishara Investments LP300,000$2.34M2.7%N/A0.142%
2/18/2026Janus Henderson Group PLC7,404,386$57.79M0.0%+7,807.2%3.514%
2/18/2026Gotham Asset Management LLC216,946$1.69M0.0%-36.9%0.103%
2/18/2026Elmind Capital LP2,150,000$16.77M4.9%N/A1.020%
2/18/2026Engineers Gate Manager LP224,543$1.75M0.0%-49.3%0.107%
2/18/2026Eversept Partners LP2,992,895$23.35M1.2%+117.9%1.420%
2/18/2026Baker BROS. Advisors LP2,822,727$22.02M0.1%N/A1.339%
2/18/2026Banco Bilbao Vizcaya Argentaria S.A.19,249$148K0.0%N/A0.009%
2/17/2026ADAR1 Capital Management LLC45,000$351K0.0%N/A0.021%
2/17/2026Schonfeld Strategic Advisors LLC141,449$1.10M0.0%-15.2%0.067%
2/17/2026AQR Capital Management LLC704,291$5.49M0.0%-29.6%0.334%
2/17/2026Cetera Investment Advisers12,330$96K0.0%+13.8%0.006%
2/17/2026Abel Hall LLC24,898$194K0.0%N/A0.012%
2/17/2026Lazard Asset Management LLC69,598$543K0.0%+30.6%0.033%
2/17/2026Jain Global LLC74,455$581K0.0%N/A0.035%
2/17/2026RA Capital Management L.P.15,827,186$123.45M1.3%N/A7.510%
2/17/2026Jump Financial LLC910,930$7.11M0.1%-1.5%0.432%
2/17/2026Price T Rowe Associates Inc. MD177,392$1.38M0.0%+9.9%0.084%
2/17/2026Vinva Investment Management Ltd18,733$146K0.0%-64.7%0.009%
2/17/2026Osaic Holdings Inc.82,766$646K0.0%+34.0%0.039%
2/17/2026Integral Health Asset Management LLC200,000$1.56M0.1%N/A0.095%
2/17/2026California State Teachers Retirement System191,847$1.50M0.0%+5.1%0.091%
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
2/17/2026Diadema Partners LP190,928$1.49M0.3%N/A0.091%
2/17/2026Russell Investments Group Ltd.229,226$1.79M0.0%-27.1%0.109%
2/17/2026State of Wisconsin Investment Board347,190$2.71M0.0%-7.6%0.165%
2/17/2026Captrust Financial Advisors17,740$138K0.0%-9.4%0.008%
2/17/2026Royal Bank of Canada161,456$1.26M0.0%-12.9%0.077%
2/17/2026Graham Capital Management L.P.83,876$654K0.0%-68.7%0.040%
2/17/2026Persistent Asset Partners Ltd51,701$403K0.2%N/A0.025%
2/17/2026Rice Hall James & Associates LLC1,904,146$14.85M0.8%+1.3%0.904%
2/17/2026University of Texas Texas AM Investment Management Co.64,507$503K0.1%N/A0.031%
2/16/2026Squarepoint Ops LLC1,659,192$12.94M0.0%+49.7%0.787%


BCRX Institutional Ownership - Frequently Asked Questions

During the previous two years, 309 institutional investors and hedge funds held shares of BioCryst Pharmaceuticals. The most heavily invested institutionals were Vanguard Group Inc. ($173.73M), RA Capital Management L.P. ($123.45M), Deerfield Management Company L.P. ($92.36M), State Street Corp ($86.37M), Janus Henderson Group PLC ($84.85M), Perceptive Advisors LLC ($70.77M), and Deerfield Management Company L.P. Series C ($61.25M).Learn more on BioCryst Pharmaceuticals' institutional investors.

85.88% of BioCryst Pharmaceuticals' stock is owned by institutional investors. Learn more on BCRX's institutional investor holdings.

Of the 269 institutional investors that purchased BioCryst Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($15.83M), Janus Henderson Group PLC ($8.81M), Deerfield Management Company L.P. ($7.48M), Perceptive Advisors LLC ($7.43M), Arrowstreet Capital Limited Partnership ($5.03M), Bank of America Corp DE ($4.96M), and Assenagon Asset Management S.A. ($3.61M).

Institutional investors have bought a total of 109,747,502 shares in the last 24 months. This purchase volume represents approximately $916.87M in transactions.

Of the 110 institutional investors that sold BioCryst Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Assenagon Asset Management S.A. ($3.39M), Avoro Capital Advisors LLC ($3.25M), Voloridge Investment Management LLC ($2.02M), Millennium Management LLC ($1.87M), Alkeon Capital Management LLC ($1.75M), Ameriprise Financial Inc. ($1.64M), and Renaissance Technologies LLC ($1.36M).

Institutional investors have sold a total of 33,069,925 shares in the last 24 months. This volume of shares sold represents approximately $269.06M in transactions.



This page (NASDAQ:BCRX) was last updated on 7/6/2026 by MarketBeat.com Staff.
From Our Partners